Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

COVID-19 Monoclonal Antibody Therapeutics Communications Toolkit


The all-of-community approach to combating COVID-19 continues. It is more important than ever that clear, accurate, and consistent information is provided to the public regarding prevention and treatment. While vaccines are at the heart of ending the pandemic, COVID-19 treatments known as monoclonal antibodies are also available and have the potential to save lives and relieve burden on our nation’s health care system. It is imperative that partners at all levels of government and within the private sector work together to ensure widest dissemination of information regarding these treatments.

This communications toolkit was developed by the Federal COVID-19 Response Team to assist with this priority effort.

IV hand

What’s in the COVID-19 monoclonal antibody communications toolkit?

Who should use this resource?

  • Health communicators
  • Health department officials
  • Health care providers
  • Health system administrators
  • Monoclonal antibody treatment sites
  • Entities involved with monoclonal antibody distribution and/or administration

About Monoclonal Antibody Treatments

Monoclonal antibodies can be used to treat eligible, non-hospitalized patients who have tested positive for COVID-19 and have mild to moderate symptoms. These treatments mimic our immune system’s response to SARS-CoV-2 (the infection that causes COVID-19) and are available to eligible patients 12 years and older with a high risk of progressing to severe forms of COVID-19 or being hospitalized.

In this toolkit, you will find a series of resources developed by the Federal COVID-19 response team and other partners on monoclonal antibody therapeutics. You will find helpful tools for infusion sites, healthcare providers, patients, communicators, and other helpful resources for your state.

For a complete list of the latest monoclonal antibody therapeutic products authorized under Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA), visit FDA’s website.

Contact the Combat COVID Monoclonal Antibodies Call Center at 1-877-332-6585 or contact us at for more information. You can also speak via our live web chat, 24/7, 365, by visiting

Digital Communications Tools

The following resources have an been hand selected based for digital and social media promotion:

Monoclonal Treatment Products

Resources for Treatment Sites

The following resources have an been hand selected for treatment site looking to open and procure monoclonal antibody therapeutics:

Locating and Opening Up Treatment Sites

Payment and Allocation

Resources for Providers

The following resources have an been hand selected based for healthcare providers:

Resources for Patients

Resources for patients or individuals with a loved one testing positive for COVID-19:

Additional Resources

Other COVID-19 related resources for more information:

  • This page last reviewed: March 09, 2022